GT Biopharma (GTBP) has had the highest return since September 1, 2026 by a US stock, returning 3,924.2%.
| ASSET | % RETURN |
|---|---|
GT Biopharma (GTBP) | 3,924.22% |
Cytosorbents Crp (CTSO) | 1,714.37% |
Neurosense Therapeutics (NRSN) | 1,519.82% |
Pop Culture (CPOP) | 1,133.94% |
Shengfeng Development Limited Class A Ordinary Shares (SFWL) | 838.68% |
Hub Cyber Security Ltd Ordinary Shares (HUBC) | 755.41% |
error (ZVZZT) | 628.11% |
TNL Mediagene Ordinary Shares (TNMG) | 462.27% |
La Rosa Holdings Corp Common Stock (LRHC) | 441.63% |
NextNRG (NXXT) | 409.01% |
Future Fintech (FTFT) | 211.96% |
Indaptus Therapeutics (INDP) | 185.45% |
PDS Biotechnology (PDSB) | 178.71% |
Elite Express Holding Inc Class A Common Stock (ETS) | 123.14% |
PS International Group Ltd Ordinary Shares (PSIG) | 115.09% |
ReTo Eco-Solutions (RETO) | 105.88% |
Nature Wood Group Limited American Depositary Shares (NWGL) | 104.71% |
FAST TRACK (FTRK) | 100% |
Swvl (SWVL) | 78.01% |
CEA Industries (BNC) | 75.67% |
Diana Shipping Inc WT (DSX.WT) | 73.68% |
Katapult (KPLT) | 71.11% |
error (ATER) | 65.52% |
17 Education Technology (YQ) | 65.02% |
ChargePoint (CHPT) | 60.36% |